Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™

JUPITER, Fla. & DURHAM, N.C. – Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to the role of Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240403857451/en/ Scott Plesha, CEO, Pelthos Therapeutics (Photo: Business Wire)

The release as fetched from its publisher. pelthos.com ↗